. 2023 Jun 5;330(1):43–51. doi: 10.1001/jama.2023.9526

Table 1. Characteristics of Patients Diagnosed With Cancer in California and Georgia and Reported to Surveillance, Epidemiology, and End Results (SEER) Registries From 2013 to 2019 by Germline Genetic Testing Status^a.

	Breast (female)		Breast (male)		Colorectal		Endometrial		Lung		Ovarian		Pancreatic		Prostate		Multiple cancer types		All other cancer types
	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %	No.	Tested, %
Overall	203 575	26.0	1344	50.0	93 562	5.6	38 324	6.4	103 139	0.3	16 444	38.6	30 595	5.6	140 810	1.1	231 261	7.5	510 548	0.9
State
California	159 165	24.7	984	49.1	72 281	5.6	30 728	6.1	74 026	0.3	13 347	37.5	24 047	5.9	104 471	1.2	180 456	7.4	400 579	0.9
Georgia	44 410	30.6	360	52.5	21 281	5.9	7596	7.3	29 113	0.2	3097	43.1	6548	4.5	36 339	0.8	50 805	7.6	109 969	0.8
Sex^b
Female	203 575	26.0	NA	NA	44 460	6.2	38 324	6.4	50 274	0.5	16 444	38.6	15 039	5.8	NA	NA	119 761	13.0	223 276	1.4
Male	NA	NA	1344	50.0	49 102	5.1	NA	NA	52 865	0.2	NA	NA	15 556	5.4	140 810	1.1	111 500	1.5	287 272	0.6
Age group at diagnosis, y
20-39	10 569	69.5	36	55.6	4014	28.8	1719	14.7	833	2.8	946	39.4	509	16.7	67	6.0	2980	19.3	49 721	2.2
40-49	34 645	56.7	117	55.6	9160	19.4	3622	10.8	2828	1.8	1871	45.9	1478	12.6	3035	2.9	8527	26.8	51 496	2.0
50-59	50 867	25.0	284	47.5	22 419	5.1	10 462	6.8	15 329	0.5	3832	44.1	5017	7.6	27 877	1.4	26 876	15.1	100 773	1.0
60-69	56 394	15.7	398	55.3	24 948	2.9	13 680	5.6	31 660	0.3	4564	41.6	9087	6.5	60 888	1.0	59 743	9.1	134 498	0.7
70-79	35 037	10.3	310	49.4	18 326	2.0	6473	4.2	32 439	0.2	3370	36.1	8334	4.6	37 263	0.9	73 545	5.0	103 458	0.4
≥80	16 063	4.4	199	39.7	14 695	0.8	2368	2.0	20 050	0	1861	16.7	6170	1.5	11 680	0.6	59 590	2.0	70 602	0.1
Race and ethnicity^c
Asian	26 749	23.4	117	44.4	11 828	4.6	4602	6.3	11 695	0.4	2084	36.5	3476	5.9	9369	1.1	15 271	10.5	44 184	0.9
Black	23 957	26.0	212	44.8	11 528	4.4	4384	4.4	12 580	0.2	1390	29.4	3848	3.3	24 007	0.7	20 278	7.7	41 730	0.7
Hispanic	37 294	26.8	153	43.1	18 350	6.5	8116	6.0	10 532	0.3	3396	34.3	5572	4.8	21 360	0.7	24 266	9.1	91 939	1.1
Non-Hispanic White	112 660	26.5	844	53.7	50 356	5.9	20 705	7.0	67 657	0.3	9438	41.9	17 525	6.3	78 893	1.3	169 841	6.9	313 091	0.9
Other^d	2915	20.6	18	33.3	1500	4.0	517	4.4	675	0.1	136	40.4	174	5.2	7181	0.6	1605	5.2	19 604	0.7

Abbreviation: NA, not applicable.

^{^a}

Includes genetic tests performed after and within 2 years of diagnosis from January 1, 2013, through March 31, 2021.

^{^b}

Those coded as other (n = 328) were excluded (eFigure 1 in Supplement 1).

^{^c}

Race and ethnicity data were collected by self-report and the categories are mutually exclusive. The categories were based on definitions from the US Census Bureau. Race was derived from the SEER race1 variable (North American Association of Central Cancer Registries [NAACCR] variable 160). Ethnicity (Hispanic ethnicity) was obtained from NAACCR Hispanic identification algorithm–derived Hispanic origin (NAACCR variable 191). All patients identified as Hispanic were coded as Hispanic regardless of race.

^{^d}

Includes patients with SEER race1 variable coded as Native American, unknown, and Other.

Table 1. Characteristics of Patients Diagnosed With Cancer in California and Georgia and Reported to Surveillance, Epidemiology, and End Results (SEER) Registries From 2013 to 2019 by Germline Genetic Testing Statusa.

Table 1. Characteristics of Patients Diagnosed With Cancer in California and Georgia and Reported to Surveillance, Epidemiology, and End Results (SEER) Registries From 2013 to 2019 by Germline Genetic Testing Status^a.